Holen Sie sich die Stockscreener-App
1.71
1.71%
-0.04
Schlusskurs vom Vortag:
$1.75
Offen:
$1.75
24-Stunden-Volumen:
63,062
Relative Volume:
0.09
Marktkapitalisierung:
$7.84M
Einnahmen:
$32.96M
Nettoeinkommen (Verlust:
$-4.23M
KGV:
-0.011
EPS:
-155.3294
Netto-Cashflow:
$-14.00M
1W Leistung:
-11.79%
1M Leistung:
+15.44%
6M Leistung:
+27.41%
1J Leistung:
-39.01%
1-Tages-Spanne:
$1.71
$1.76
1-Wochen-Bereich:
$1.71
$2.13
52-Wochen-Spanne:
$1.1693
$3.90
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Firmenname
Sunshine Biopharma Inc
Sektor
Telefon
954-330-0684
Adresse
333 LAS OLAS WAY, FORT LAUDERDALE
Vergleichen Sie SBFM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.72 | 8.59M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
143.01 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.46 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.2112 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.09 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.22 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Sunshine Biopharma Inc Aktie (SBFM) Neueste Nachrichten
Tick level data insight on Sunshine Biopharma Inc. volatilityOptions Play & Weekly Return Optimization Plans - newser.com
What institutional flow reveals about Sunshine Biopharma Inc. Equity Warrant2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
How resilient is Sunshine Biopharma Inc. stock in market downturnsJuly 2025 Review & Real-Time Chart Breakout Alerts - newser.com
How Sunshine Biopharma Inc. stock benefits from tech adoptionJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
Custom watchlist performance reports with Sunshine Biopharma Inc. Equity WarrantJuly 2025 Trends & Verified Momentum Watchlists - newser.com
How Sunshine Biopharma Inc. Equity Warrant stock trades during market volatilityJuly 2025 Short Interest & Weekly Stock Performance Updates - newser.com
How Sunshine Biopharma Inc. Equity Warrant stock performs in weak economyQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - newser.com
Published on: 2025-10-31 02:46:44 - newser.com
How Sunshine Biopharma Inc. stock responds to policy changesTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com
Is Sunshine Biopharma Inc. stock attractive for long term wealth buildingGap Up & Weekly Return Optimization Plans - newser.com
What catalysts could drive Sunshine Biopharma Inc. Equity Warrant stock higherJuly 2025 Setups & Verified Technical Trade Signals - newser.com
Should you wait for a breakout in Sunshine Biopharma Inc. Equity WarrantCPI Data & Stock Market Timing Techniques - newser.com
Is a relief rally coming for Sunshine Biopharma Inc. Equity Warrant holdersWeekly Gains Summary & Technical Buy Zone Confirmations - newser.com
Volatility clustering patterns for Sunshine Biopharma Inc.Earnings Beat & High Accuracy Buy Signal Tips - newser.com
How to forecast Sunshine Biopharma Inc. Equity Warrant trends using time seriesJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - newser.com
Why analysts remain bullish on Sunshine Biopharma Inc. stockJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
How sentiment analysis helps forecast Sunshine Biopharma Inc. Equity WarrantTrade Risk Summary & Short-Term High Return Ideas - newser.com
Published on: 2025-10-30 06:48:27 - newser.com
Is Sunshine Biopharma Inc. stock a dividend growth opportunityQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Published on: 2025-10-30 05:48:39 - newser.com
Analyzing Sunshine Biopharma Inc. Equity Warrant with risk reward ratio chartsJuly 2025 Rallies & Short-Term High Return Strategies - newser.com
Published on: 2025-10-29 21:50:35 - newser.com
What to expect from Sunshine Biopharma Inc. in the next 30 daysWall Street Watch & Weekly Consistent Profit Watchlists - newser.com
Published on: 2025-10-29 21:36:19 - newser.com
Published on: 2025-10-29 21:36:13 - newser.com
When is the best time to exit Sunshine Biopharma Inc. Equity WarrantJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Custom strategy builders for tracking Sunshine Biopharma Inc. Equity Warrant2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
Is Sunshine Biopharma Inc. stock attractive for passive investorsAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
Published on: 2025-10-29 04:04:59 - newser.com
Is Sunshine Biopharma Inc. stock attractive after correctionWeekly Stock Recap & Weekly Breakout Watchlists - newser.com
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM) - standard-journal.com
Dow Update: Is Sunshine Biopharma Inc. stock a top pick in earnings seasonJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - Fundação Cultural do Pará
Will Sunshine Biopharma Inc. Equity Warrant stock recover faster than marketQuarterly Risk Review & Step-by-Step Trade Execution Guides - Fundação Cultural do Pará
Sunshine Biopharma stock rises after Health Canada approval for Domperidone - Investing.com Nigeria
Sunshine Biopharma (SBFM) Gains Health Canada Approval for Dompe - GuruFocus
Sunshine Biopharma subsidiary receives Health Canada approval for drug - Investing.com
Published on: 2025-10-28 07:09:39 - newser.com
Sunshine Biopharma subsidiary receives Health Canada approval for drug By Investing.com - Investing.com Nigeria
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea - Caledonian Record
Sunshine Bio (NASDAQ: SBFM) gains Health Canada approval for Domperidone in $1.36B market - Stock Titan
How geopolitical tensions affect Sunshine Biopharma Inc. Equity Warrant stockJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com
Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.02%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):